Cellosaurus logo
expasy logo

Cellosaurus RM-P1 (CVCL_JG30)

[Text version]
Cell line name RM-P1
Accession CVCL_JG30
Resource Identification Initiative To cite this cell line use: RM-P1 (RRID:CVCL_JG30)
Comments Population: Japanese.
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
Disease Primary effusion lymphoma (NCIt: C6915)
Primary effusion lymphoma (ORDO: Orphanet_48686)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 63Y
Category Cancer cell line
STR profile Source(s): JCRB=JCRB1650

Markers:
AmelogeninX
CSF1PO10,11
D5S8189,12
D7S82010
D13S3179,14
D16S53912
TH019
TPOX8,11
vWA17,18

Run an STR similarity search on this cell line
Publications

PubMed=12215016; DOI=10.1007/BF02982580
Miyagi J.-i., Masuda M., Takasu N., Nagasaki A., Shinjyo T., Uezato H., Kakazu N., Tanaka Y.
Establishment of a primary effusion lymphoma cell line (RM-P1) and in vivo growth system using SCID mice.
Int. J. Hematol. 76:165-172(2002)

PubMed=19521981; DOI=10.1002/ijc.24521
Takahashi-Makise N., Suzu S., Hiyoshi M., Ohsugi T., Katano H., Umezawa K., Okada S.
Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
Int. J. Cancer 125:1464-1472(2009)

PubMed=29892436; DOI=10.1098/rsos.172472; PMCID=PMC5990783
Shioda S., Kasai F., Watanabe K., Kawakami K., Ohtani A., Iemura M., Ozawa M., Arakawa A., Hirayama N., Kawaguchi E., Tano T., Miyata S., Satoh M., Shimizu N., Kohara A.
Screening for 15 pathogenic viruses in human cell lines registered at the JCRB Cell Bank: characterization of in vitro human cells by viral infection.
R. Soc. Open Sci. 5:172472-172472(2018)

Cross-references
Cell line collections (Providers) JCRB; JCRB1650
Encyclopedic resources Wikidata; Q54950635
Entry history
Entry creation15-May-2017
Last entry update02-May-2024
Version number8